Workers in turmoil at the Biomedica Foscama in Ferentino. Yesterday they went on strike by stationing themselves in front of the gates of the well-known pharmaceutical industry and on Monday it is not known whether they will cross their arms.
It is certain that the approximately 90 employees do not feel relaxed, this can also be perceived by some of them reflections. They explained after an assembly outside the industry: “Seventy years and more of history of one prestigious pharmaceutical company Italian are at risk of being canceled forever, leaving patients in important therapeutic areas without essential support for their therapies. In addition, about 90 families are likely to join the long list of those who lose their jobs. There Biomedical Foscamadi Ferentino, even if in bankruptcy management, has continued to operate until today thanks to the strength of its products and workers. The company has a lot market, national and international orders are growing, but the financial problems of recent years prevent the purchase of raw materials for production”. Couldn't miss theirs appeal to the bodies responsible for it to come averted there closure of the company.
Red Fer
Related news: Ferentino. Biomedica Foscama also closes its doors.
L’APPELLO DEI LAVORATORI
“Over 70 years of history of a prestigious Italian pharmaceutical company risk being erased forever, leaving patients in important therapeutic areas without essential support for their therapies. Furthermore, about 90 families are about to join the long list of those who lose their jobs and will never find them again".
This was stated in a note released today by the workers of Biomedica Foscama di Ferentino, who thus launch a heartfelt appeal to the institutions in charge. “In fact – they continue -, despite being in bankruptcy management, the Ferentine industry has continued to operate until today thanks to the strength of its products and its workers. The company is a unique pole of its kind, as it specializes in the manufacture of sterile injectable products for oncological supportive care, neuro-degenerative diseases, liver detoxification and parenteral nutrition of patients.
The lease of the business branch to a Roman company has expired for two years and the tenant herself is now in a deep crisis. The company has a large market, national and international orders are growing, but the financial problems of the last period prevent the purchase of raw materials intended for production”.
“We are faced with a situation bordering on the paradox - concludes the employee document - in which there is a thriving market, patients need the drugs produced, employees have skills and a desire to rise again but everything clashes with the logic of questionable management, slow decision-making, difficulty in managing the emergency. The rescue of Biomedica Foscama di Ferentino and the consequent industrial relaunch of the site is still possible but action must be taken with the utmost urgency, also because there could be serious industrialists interested in investing for the relaunch. The authorities in charge must give greater speed to their action, so that the closure of the company does not occur".